Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S10.11
P/E—
Fwd P/E34.50
PEG3.56
52W— – —
RSI—
Target$707.0 (+24.1%)
Beta1.55
Div—
Loading chart…
RSI (14)
Loading patterns…
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 55
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
0Bullish
1Bearish
0Neutral
▼ Double Top — Two peaks ~$589.82 — bearish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$707.0
+24.1% upside
Low $470
—
High $805
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | — | ↔ Maintain | 2026-07-27 |
| Citigroup | Neutral | — | ● Initiate | 2026-04-15 |
| Stifel | Buy | — | ↔ Maintain | 2026-03-31 |
| Piper Sandler | Neutral | — | ↔ Maintain | 2026-02-09 |
| Barclays | Overweight | — | ↔ Maintain | 2026-02-05 |
| BTIG | Buy | — | ↔ Maintain | 2026-02-03 |
| Morgan Stanley | Overweight | — | ↔ Maintain | 2025-11-04 |
| JP Morgan | Overweight | — | ↔ Maintain | 2025-11-04 |
UBS
2026-07-27
Neutral
↔ Maintain
Citigroup
2026-04-15
Neutral
● Initiate
Stifel
2026-03-31
Buy
↔ Maintain
Piper Sandler
2026-02-09
Neutral
↔ Maintain
Barclays
2026-02-05
Overweight
↔ Maintain
BTIG
2026-02-03
Buy
↔ Maintain
Morgan Stanley
2025-11-04
Overweight
↔ Maintain
JP Morgan
2025-11-04
Overweight
↔ Maintain
Profitability
Gross Margin
62.05%TTM
Op. Margin
31.78%TTM
ROE
72.91%TTM
Rev. Growth
14.30%YoY
Free Cash Flow
786.84MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
71.04MRQ
Current Ratio
1.12MRQ
Cash
200.53MMRQ
Total Debt
1.11BMRQ
Net Debt
—MRQ
How IDXX Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 44.95B |
| Enterprise Value | 45.85B |
| Trailing P/E | 41.86 |
| Forward P/E | 34.50 |
| PEG Ratio (5yr) | 3.56 |
| Price/Sales (ttm) | 10.11 |
| Price/Book (mrq) | 29.01 |
| EV/Revenue | 10.31 |
| EV/EBITDA | 29.66 |
Share Statistics
| Avg Vol (3m) | 651.38K |
| Shares Outstanding | 78.88M |
| Float | 78.58M |
| % Held by Insiders | 0.22% |
| % Held by Institutions | 96.16% |
| Short Ratio | 2.84 |
| Short % of Float | 3.04% |
Profitability
| Gross Margin | 62.05% |
| Operating Margin (ttm) | 31.78% |
| Profit Margin | 24.63% |
| Return on Assets (ttm) | 26.46% |
| Return on Equity (ttm) | 72.91% |
Income Statement
| Revenue (ttm) | 4.45B |
| Revenue Growth (yoy) | 14.30% |
| Gross Profit (ttm) | 2.76B |
| EBITDA | 1.55B |
| Net Income (ttm) | 1.10B |
| Diluted EPS (ttm) | 13.61 |
| EPS Growth (yoy) | 17.20% |
Balance Sheet
| Total Cash (mrq) | 200.53M |
| Total Debt (mrq) | 1.11B |
| Debt / Equity (mrq) | 71.04 |
| Current Ratio (mrq) | 1.12 |
| Book Value / Share | 19.64 |
| Operating CF (ttm) | 1.21B |
| Free Cash Flow (ttm) | 786.84M |
Trading & Dividends
| Beta (5Y) | 1.55 |
| 50-Day MA | 555.77 |
| 200-Day MA | 621.46 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 96.16%
Insider 0.22%
Public 3.6%
Short Interest
3.04% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in IDXX in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | FENNELL GEORGE | Officer | 639 | — | |
| 2026-05-07 | SZOSTAK MARGARET ANNE | Director | 257 | — | |
| 2026-05-07 | JUNIUS DANIEL M | Director | 257 | — | |
| 2026-05-07 | PEACOCK KAREN | Director | 101 | — | |
| 2026-05-07 | KINGSLEY LAWRENCE D | Director | 339 | — | |
| 2026-05-07 | HOOLEY JOSEPH L. | Director | 158 | — | |
| 2026-05-07 | VANDEBROEK SOPHIE V | Director | 257 | — | |
| 2026-04-30 | HOOLEY JOSEPH L. | Director | Stock Award(Grant) at price 560.80 per share. | 43 | $24,114 |
| 2026-03-03 | UNDERBERG SHARON E | General Counsel | Conversion of Exercise of derivative security at price 505.53 per share. | 197 | $99,589 |
| 2026-03-03 | HUNT NIMRATA K | Officer | Sale at price 634.57 per share. | 1,758 | $1,115,577 |
| 2026-02-27 | MAZELSKY JONATHAN JAY | Chief Executive Officer | Conversion of Exercise of derivative security at price 141.60 - 505.53 per share. | 23,523 | $3,402,551 |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Chief Executive Officer | Sale at price 650.67 - 663.04 per share. | 23,326 | $15,338,081 |
| 2026-02-26 | HUNT NIMRATA K | Officer | Sale at price 661.54 per share. | 2,693 | $1,781,531 |
| 2026-02-19 | ERICKSON MICHAEL G | Officer | Conversion of Exercise of derivative security at price 141.60 - 544.08 per share. | 7,770 | $1,460,329 |
| 2026-02-17 | VANDEBROEK SOPHIE V | Director | Conversion of Exercise of derivative security at price 333.90 per share. | 945 | $315,536 |
| 2026-02-17 | VANDEBROEK SOPHIE V | Director | Sale at price 628.56 - 628.65 per share. | 1,464 | $920,293 |
| 2026-02-17 | ERICKSON MICHAEL G | Officer | Sale at price 623.76 - 629.86 per share. | 5,371 | $3,369,666 |
| 2026-02-13 | SMITH MARTIN ALEXANDER | Officer | 1,004 | — | |
| 2026-02-13 | UNDERBERG SHARON E | General Counsel | 832 | — | |
| 2026-02-13 | LANE MICHAEL J | Officer | 1,092 | — | |
| 2026-02-13 | HUNT NIMRATA K | Officer | 2,587 | — | |
| 2026-02-13 | JOHNSON MICHAEL PERKINS | Officer | 573 | — | |
| 2026-02-13 | SCHRECK MICHAEL | Officer | 1,959 | — | |
| 2026-02-13 | ERICKSON MICHAEL G | Officer | 2,363 | — | |
| 2026-02-13 | EMERSON ANDREW | Chief Financial Officer | 456 | — |
FENNELL GEORGE
Officer
2026-06-01
639 sh
—
SZOSTAK MARGARET ANNE
Director
2026-05-07
257 sh
—
JUNIUS DANIEL M
Director
2026-05-07
257 sh
—
PEACOCK KAREN
Director
2026-05-07
101 sh
—
KINGSLEY LAWRENCE D
Director
2026-05-07
339 sh
—
HOOLEY JOSEPH L.
Director
2026-05-07
158 sh
—
VANDEBROEK SOPHIE V
Director
2026-05-07
257 sh
—
HOOLEY JOSEPH L.
Director
Stock Award(Grant) at price 560.80 per share.
2026-04-30
43 sh
$24,114
UNDERBERG SHARON E
General Counsel
Conversion of Exercise of derivative security at price 505.53 per share.
2026-03-03
197 sh
$99,589
HUNT NIMRATA K
Officer
Sale at price 634.57 per share.
2026-03-03
1,758 sh
$1,115,577
MAZELSKY JONATHAN JAY
Chief Executive Officer
Conversion of Exercise of derivative security at price 141.60 - 505.53 per share.
2026-02-27
23,523 sh
$3,402,551
MAZELSKY JONATHAN JAY
Chief Executive Officer
Sale at price 650.67 - 663.04 per share.
2026-02-26
23,326 sh
$15,338,081
HUNT NIMRATA K
Officer
Sale at price 661.54 per share.
2026-02-26
2,693 sh
$1,781,531
ERICKSON MICHAEL G
Officer
Conversion of Exercise of derivative security at price 141.60 - 544.08 per share.
2026-02-19
7,770 sh
$1,460,329
VANDEBROEK SOPHIE V
Director
Conversion of Exercise of derivative security at price 333.90 per share.
2026-02-17
945 sh
$315,536
VANDEBROEK SOPHIE V
Director
Sale at price 628.56 - 628.65 per share.
2026-02-17
1,464 sh
$920,293
ERICKSON MICHAEL G
Officer
Sale at price 623.76 - 629.86 per share.
2026-02-17
5,371 sh
$3,369,666
SMITH MARTIN ALEXANDER
Officer
2026-02-13
1,004 sh
—
UNDERBERG SHARON E
General Counsel
2026-02-13
832 sh
—
LANE MICHAEL J
Officer
2026-02-13
1,092 sh
—
HUNT NIMRATA K
Officer
2026-02-13
2,587 sh
—
JOHNSON MICHAEL PERKINS
Officer
2026-02-13
573 sh
—
SCHRECK MICHAEL
Officer
2026-02-13
1,959 sh
—
ERICKSON MICHAEL G
Officer
2026-02-13
2,363 sh
—
EMERSON ANDREW
Chief Financial Officer
2026-02-13
456 sh
—